Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

General Information Age Group Adults Status Active, not recruiting Protocol Number NCT02928497 Background Information The ASAP-TOO study is a prospective, randomized, multi-center, global investigation to establish the safety and effectiveness of the Watchman Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anti-coagulation therapy to reduce the risk of stroke. Subjects are randomized in a ratio of 2 device to 1 control to receive the Watchman LAA closure device or the control treatment of single antiplatelet medication or no medication at the discretion of the study physician. Offered At Inova Fairfax Hospital 3300 Gallows Rd. Falls Church, VA 22042 Principal Investigator Matthew Sherwood, MD Contact Information Contact Name Tracy Plummer Contact Phone 703-776-3567 Contact Email Send Email